Alnylam Pharmaceuticals (ALNY) P/E ratio

P/E ratio today
7.9×

Only 1 fiscal year of P/E ratio is on record here for Alnylam Pharmaceuticals (ALNY); a history needs at least 3. Alnylam Pharmaceuticals (ALNY) trades at 7.9× its earnings per share over the last twelve months. Figures as of 18 Nov 2026, 09:56 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
7.9×
P/E ratio, fiscal 2025
170.7×
Fiscal years on record
12025–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/E ratio needs at least 3 fiscal years; one is on record here for Alnylam Pharmaceuticals. Nothing is estimated to fill the gap. What is on record is in the table below.

Alnylam Pharmaceuticals P/E ratio, year by year

Alnylam Pharmaceuticals (ALNY) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today7.9×—$156.50—
2025170.7×—$397.65$2.33
2024——$235.31-$2.18
2023——$191.41-$3.52
2022——$237.65-$9.30
2021——$169.58-$7.20
2020——$129.97-$7.46
2019——$115.17-$8.11
2018——$72.91—
2017——$127.05—
2016——$37.44—
2015——$94.14—
2014——$97.00—
2013——$64.30—
2012——$18.25—
2011——$8.15—
2010——$9.86—
2009——$17.62—
2008——$24.73—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Alnylam Pharmaceuticals and comparable companies
CompanyP/E ratio
Tenet Healthcare THC8.2×
Alnylam Pharmaceuticals ALNY7.9×
Zimmer Biomet Holdings ZBH25.8×
Medpace Holdings MEDP36.3×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on ALNY

Alnylam Pharmaceuticals, figure by figure

Alnylam Pharmaceuticals (ALNY) overview: price, valuation and scorecardAll health care companies by market value

Alnylam Pharmaceuticals P/E ratio: questions and answers

What is Alnylam Pharmaceuticals's P/E ratio?

Alnylam Pharmaceuticals (ALNY) trades at 7.9× its earnings per share over the last twelve months.

How is Alnylam Pharmaceuticals's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alnylam Pharmaceuticals (ALNY) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ALNY/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.